23.02.2016 14:35:10
|
ANI Pharma Q4 Profit Plunges
(RTTNews) - ANI Pharmaceuticals Inc. (ANIP) Tuesday announced fourth quarter net income of $2.876 million or $0.25 per share, compared to $21.006 million or $1.82 per share last year. On an adjusted basis, net income was $6.042 million or $0.52 per share.
On average, 3 analysts polled by Thomson Reuters expected the company to earn $0.60 per share. Analysts estimates usually exclude special items.
Revenue for the quarter declined to $18.035 from $21.037 million in the previous year. Wall Street expected $18.13 million.
Looking ahead to full year 2016, the company expects earnings per share to be $0.30 to $0.65 and adjusted net income per share to be between $2.94 to $3.31. Street projects $2.99 per share on revenue of $91.83 million.
Revenue for the quarter in expected to be between $105 million to $120 million.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biosante Pharmaceuticals Incmehr Nachrichten
07.11.24 |
Ausblick: Biosante Pharmaceuticals verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
05.08.24 |
Ausblick: Biosante Pharmaceuticals stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) |
Analysen zu Biosante Pharmaceuticals Incmehr Analysen
Aktien in diesem Artikel
Biosante Pharmaceuticals Inc | 51,50 | 0,00% |